Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Liraglutide Market Grow Over the Forecast Period Based on Its Expected CAGR?

In the past few years, the market size of liraglutide has experienced significant growth. It is predicted to expand from $6.38 billion in 2024 to $6.95 billion in 2025, maintaining a compound annual growth rate (CAGR) of 9.0%. This surge during the historic period can be credited to the rise in type 2 diabetes diagnoses, increasing obesity prevalence, extensive clinical research, heightened understanding of diabetes-related complications, and advancements in drug delivery systems.

Predictions indicate a steady surge for the liraglutide market over the upcoming years, resulting in its steady climb to $9.66 billion by 2029, with an 8.6% compound annual growth rate (CAGR). This boost can be attributed to factors such as the expansion of insurance and reimbursement policies, enhancements in healthcare infrastructure, rising awareness through educational efforts, an aging population, and an increased occurrence of diabetes. Key trends likely to shape the market in the forecast period involve artificial intelligence and machine learning utilisation, wearable technology popularity, constant glucose monitoring incorporation, biotech progress, and the proliferation of digital health platforms.

What Combination of Drivers Is Leading to Accelerated Growth in the Liraglutide Market?

The rise in the number of diabetes cases is predicted to fuel the expansion of the liraglutide market. Diabetes is a long-term ailment in which the body is unable to adequately control blood sugar levels, either due to a lack of sufficient insulin production or ineffective insulin usage. The prevalence of diabetes is on the rise due to circumstances like inactive lifestyles, unhealthy eating habits, and escalating obesity rates globally. Diabetes medications like liraglutide work by simulating the function of the hormone GLP-1, which boosts insulin release, reduces blood sugar levels, and encourages weight loss, thus contributing to the control of type 2 diabetes. For instance, as per a March 2024 report by the UK Government, a UK-based information website, in March 2023, the percentage of people in England with type 1 diabetes who received all 8 care processes at participating GP practices in the NDA increased to 43.8%, up from 35.2% the previous year. Hence, the growing diabetic population is propelling the liraglutide market’s growth.

Get Your Free Sample of the Global Liraglutide Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

Who Are the Dominant Players Expanding Their Reach in the Liraglutide Market?

Major companies operating in the liraglutide market are:

• Pfizer Inc._x000D_

• Roche Holding AG_x000D_

• Merck & Co. Inc._x000D_

• AbbVie Inc._x000D_

• Sanofi S.A._x000D_

What Are the Top Trends Shaping the Evolution of the Liraglutide Market?

Key players in the liraglutide market are innovating new products, including generic GLP-1, to broaden treatment choices and cater to the market’s need for more budget-friendly options. Generic GLP-1 denotes forms of GLP-1 receptor agonists developed post-patent expiry of the original branded medications, which serve as cost-efficient solutions for ailments like type 2 diabetes and obesity. For example, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical enterprise, launched the first generic GLP-1, analogous to Victoza, in the U.S. market in June 2024, fulfilling the growing need for these treatments. Liraglutide injections are recommended for better blood sugar control in adults and children over ten who have type 2 diabetes, and to mitigate the risk of cardiovascular events in adults with type 2 diabetes and pre-existing cardiovascular complications.

Get Instant Access to the Global Liraglutide Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

What Are the Key Components of the Liraglutide Market, and How Do Its Segments Perform?

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Which Regions Are Setting the Pace for Liraglutide Market Growth?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Liraglutide Market?

Liraglutide is a GLP-1 receptor agonist used to manage type 2 diabetes and obesity. It helps lower blood sugar levels and promotes weight loss by mimicking the incretin hormone GLP-1. Administered via subcutaneous injection, it enhances insulin secretion and reduces appetite. Liraglutide is marketed under the brand names Victoza for diabetes and Saxenda for obesity.

Browse Through More Similar Reports By The Business Research Company:

Biomarkers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Anti-Aging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anti-aging-global-market-report

Antidiarrheals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antidiarrheals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: